CipherBio Weekly Digest: Week of Feb 17 – Feb 23, 2022
New Companies on CipherBio
Top Deals This Week
Minded, New York-based digital health/AI company, raises $25M in Seed round from various investors. Plexium raises $102M in Series A led by BVF Partners, L.P. and TCG X. Equip Health raises $58M in Series B led by The Chernin Group. In Series E Somatus raises $325M led by Wellington Management. Sirona Medical acquires Nines for an undisclosed amount.
|Equip Health||Series B||$58M|
This Week in Clinical Phases
NovelMed announces phase 1 clinical trial of NM8074. In phase 2 Evelo Biosciences announces trial of EDP1815 in Atopic Dermatitis. Belgium-based Pharmazz announces phase 3 clinical trial of Sovateltide for ischemic stroke. Senseonics announces FDA approval of Eversense E3 CGM System.
|Company||Product and Clinical Phase||Indications|
|NovelMed||NM8074, Phase 1||Paroxysmal Nocturnal Hemoglobinuria (PNH)|
|Evelo Biosciences||EDP1815, Phase 2||Atopic Dermatitis, Allergic Diseases|
|Pharmazz||Sovateltide, Phase 3||Ischemic Stroke|
|Senseonics||Pure-Vu® EVS System, FDA Cleared||Diabetes|
71 Life Science Companies Added
This week we added 71 life science companies to our platform.
|Ageless Biotech||TargED Biopharmaceuticals||High Tide Therapeutics|
To get all the latest life science deals and VC funding data delivered straight to your inbox weekly become a CipherBio PRO member.